Oxford University to commence human trials on a COVID-19 vaccine
Category: #health  By Nikita Chaurasia  Date: 2020-04-17
  • share
  • Twitter
  • Facebook
  • LinkedIn

Oxford University to commence human trials on a COVID-19 vaccine

The university’s vaccine programme has hired around 510 people to take part in the first trial.

As the deadly coronavirus have paved its way to almost every continent, researchers worldwide are putting in their best to develop an effective vaccine to stop this pandemic. Top scientists at the University of Oxford have recently made some developments, announcing that they are ready to commence a human trial on the potential COVID-19 vaccine.

As per reports, the vaccine has already been tested on animals and have shown promising results, facilitating the commencement of the human trial.

Apparently, alike the Oxford team, hundreds of scientists worldwide are also racing towards developing a Covid-19 jab, which could likely take around 18 months to develop. In fact, over 70 potential jabs are currently in development across the global, claims WHO.

To enable speedy vaccine development, Oxford's vaccine programme has hired around 510 people to take part in the first trial, cite sources.

As per Professor Adrian Hill, a lead researcher, their team is going to commence the human trials in the next week, as they have already tested the vaccine on several animal species.

For the record, the vaccine is developed from chimpanzees that were injected with the coronavirus to produce antibodies which could be used to boost the immune system of humans. Estimates claim that the jab, developed by the clinical teams at Oxford Vaccine Group and the Jenner Institute, could be ready by September.

However, as industry leaders and scientists are trying their best to shorten the time to introduce a vaccine in the market, public health officials claim that it could take a year to 18 months to fully validate any potential vaccine.

Meanwhile, last month, the chief scientific adviser of the UK announce that it could be at least 2021 until an effective vaccine was ready.

Source Credit: https://www.dailystar.co.uk/news/latest-news/uk-university-begins-tests-covid-21874152

  • share
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia    

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More

More News By Nikita Chaurasia

Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
Syndax Pharmaceuticals reveals data from phase 1 trial of axatilimab
By Nikita Chaurasia

According to reliable sources, Massachusetts-headquartered clinical stage biopharmaceutical company, Syndax Pharmaceuticals Inc. has revealed an updated data from its Phase 1 trial of its patent axatilimab. The company will reportedly present the dat...

Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
Xiaomi shares drop by 7.1% after raising USD 3.9 billion in equity deal
By Nikita Chaurasia

Shares of Xiaomi Corporation, a Chinese multinational electronics company, witnessed a 7.1% drop during Hong Kong trading after the company secured USD 3.91 billion in fund raising which also included the city’s top-up placement. The company h...

Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
Supercom signs a supply contract of PureSecurity EM suite in Wisconsin
By Nikita Chaurasia

Israel-based leading provider of advanced solutions for cybersecurity, IoT (Internet of Things) and e-Government sectors Supercom has reportedly signed a supply agreement to deliver its PureSecurity EM (Electronic Monitoring) product suite in Wiscons...